Otonomy, Inc.
OTICDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001493566
Otonomy, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Dec 30, 2022; 40 institutions reported holding it in 13F filings for Q3 2022, worth $8.42M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Otonomy, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −4 vs. Q2 2021
- Shares held
- 33.6M
- −3.04M (−8.3%) vs. Q2 2021
- Total value
- $64.5M
- −$17.2M (−21.1%) vs. Q2 2021
- New holders
- 10
- 8 more added
- Sold out
- 14
- 19 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 6 | $54.7K |
| Q3 2022 | 40 | $8.42M |
| Q2 2022 | 50 | $77.3M |
| Q1 2022 | 50 | $88.8M |
| Q4 2021 | 44 | $72.7M |
| Q3 2021 | 55 | $64.5M |
| Q2 2021 | 59 | $81.7M |
| Q1 2021 | 62 | $82.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Otonomy, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 7,694,038 | $14.8M | 0.06% | +471,564+6.5% | Added |
| Federated Hermes, Inc. | 4,856,200 | $9.32M | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,000,000 | $7.68M | 0.02% | +500,000+14.3% | Added |
| Vanguard Group Inc | 2,442,617 | $4.69M | 0.00% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,387,700 | $4.58M | 0.08% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 2,379,392 | $4.57M | 1.21% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,631,635 | $3.13M | 0.04% | +1,631,635 | New |
| Silverarc Capital Management, LLC | 1,017,048 | $1.95M | 1.13% | +63,614+6.7% | Added |
| Nan Fung Group Holdings Ltd | 851,000 | $1.63M | 0.52% | 00.0% | Unchanged |
| BlackRock Inc. | 799,045 | $1.53M | 0.00% | −13,551−1.7% | Reduced |
| Dimensional Fund Advisors LP | 759,675 | $1.46M | 0.00% | −423,401−35.8% | Reduced |
| Bridgeway Capital Management, LLC | 731,700 | $1.41M | 0.03% | +393,500+116.4% | Added |
| Point72 Asset Management, L.P. | 648,253 | $1.25M | 0.01% | +648,253 | New |
| Renaissance Technologies LLC | 604,926 | $1.16M | 0.00% | −118,100−16.3% | Reduced |
| Geode Capital Management, LLC | 451,702 | $867.0K | 0.00% | +24,308+5.7% | Added |
| Ghost Tree Capital, LLC | 450,000 | $864.0K | 0.28% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 380,061 | $730.0K | 0.00% | −122,251−24.3% | Reduced |
| Two Sigma Advisers, LP | 311,062 | $597.0K | 0.00% | −175,300−36.0% | Reduced |
| Ikarian Capital, LLC | 208,306 | $399.0K | 0.09% | −3,165−1.5% | Reduced |
| State Street Corp | 173,400 | $333.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 124,683 | $239.0K | 0.00% | −5,079−3.9% | Reduced |
| Walleye Capital LLC | 94,857 | $182.0K | 0.01% | −90,653−48.9% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 85,870 | $165.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 77,687 | $149.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 61,400 | $118.0K | 0.00% | +20,000+48.3% | Added |
| Engineers Gate Manager LP | 42,990 | $83.0K | 0.00% | −4,014−8.5% | Reduced |
| Two Sigma Securities, LLC | 37,661 | $72.0K | 0.01% | +37,661 | New |
| Ameriprise Financial Inc | 33,500 | $64.0K | 0.00% | −13,800−29.2% | Reduced |
| Morgan Stanley | 30,227 | $58.0K | 0.00% | −1,379−4.4% | Reduced |
| Squarepoint Ops LLC | 26,230 | $50.0K | 0.00% | −33,456−56.1% | Reduced |
| Boothbay Fund Management, LLC | 21,048 | $40.0K | 0.00% | −3,165−13.1% | Reduced |
| Group One Trading, L.P. | 19,982 | $38.0K | 0.00% | −54,108−73.0% | Reduced |
| Charles Schwab Investment Management Inc | 16,843 | $33.0K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 15,122 | $29.0K | 0.00% | −68,366−81.9% | Reduced |
| Barclays PLC | 15,240 | $29.0K | 0.00% | +10,610+229.2% | Added |
| Qube Research & Technologies Ltd | 15,233 | $29.0K | 0.00% | +15,233 | New |
| Simplex Trading, LLC | 12,646 | $27.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 13,340 | $26.0K | 0.00% | +13,340 | New |
| Schonfeld Strategic Advisors LLC | 12,900 | $25.0K | 0.00% | −1,000−7.2% | Reduced |
| ExodusPoint Capital Management, LP | 11,898 | $23.0K | 0.00% | +11,898 | New |
| Personal Cfo Solutions, LLC | 10,888 | $21.0K | 0.00% | 00.0% | Unchanged |
| Lakeview Capital Partners, LLC | 10,000 | $19.0K | 0.01% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 9,090 | $17.0K | 0.00% | −14,526−61.5% | Reduced |
| Newbridge Financial Services Group, Inc. | 8,000 | $15.0K | 0.01% | 00.0% | Unchanged |
| Bollard Group LLC | 6,442 | $12.0K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 2,774 | $5.00K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 2,000 | $4.00K | 0.00% | +2,000 | New |
| Wells Fargo & Company | 1,227 | $3.00K | 0.00% | −437−26.3% | Reduced |
| Bank of America Corp | 1,371 | $3.00K | 0.00% | +1,344+4,977.8% | Added |
| Steward Partners Investment Advisory, LLC | 1,000 | $2.00K | 0.00% | +1,000 | New |
| UBS Group AG | 400 | $1.00K | 0.00% | −9,934−96.1% | Reduced |
| Advisor Group Holdings, Inc. | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| MCF Advisors LLC | 450 | $1.00K | 0.00% | +450 | New |
| HHM Wealth Advisors, LLC | 656 | $1.00K | 0.00% | +656 | New |
| BNP Paribas Arbitrage, SA | 1 | $2 | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −3,250,000−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −1,251,256−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −280,986−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −265,648−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −211,060−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −117,758−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −112,484−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −70,319−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −69,154−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −37,754−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −32,033−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −14,145−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,902−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |